Treatment of a case of COVID-19 by intravenous immunoglobulin
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a positive-sense single-stranded RNA virus. As of today, no specific treatment has been found COVID-19. İntravenous immunoglobulin (IVIG) is a widely used therapy to prevent life-threatening infections in patients with primary and secon...
Main Authors: | Mustafa Çolak, Serdar Kalemci, Aydın Sarıhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Journal of Global Antimicrobial Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213716520303179 |
Similar Items
-
Potential therapeutic approach of intravenous immunoglobulin against COVID-19
by: Zahra Kolahchi, et al.
Published: (2021-10-01) -
Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus
by: Irene Coloretti, et al.
Published: (2021-08-01) -
Regression of Coronary Aneurysms With Intravenous Immunoglobulins and Steroids for COVID-19 Adult Multisystem Inflammatory Syndrome
by: Sarah Diakite, MD, et al.
Published: (2021-04-01) -
Intravenous Immunoglobulin Therapy in Myocarditis
by: Amir Hossein Mansourabadi, et al.
Published: (2020-08-01) -
Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study
by: Achtzehn, U., et al.
Published: (2022)